Melinta Therapeutics
Latest round
- Series B
Last raised
- Nov 2012
Total raised
- $199M
Investors
- 14
About Melinta Therapeutics
, operates as a developer of novel small molecule antibiotics for the treatment of serious infections. The company also offers products that are also used for the treatment of serious hospital gram-negative infections.
Who invested in Melinta Therapeutics
14 investors across 6 rounds
See all investors in Melinta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Melinta Therapeutics
Who invested in Melinta Therapeutics?
Melinta Therapeutics has 14 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Melinta Therapeutics raised?
Melinta Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Melinta Therapeutics last raise money?
Melinta Therapeutics's most recent round on record is a Series B, in Nov 2012.
What does Melinta Therapeutics do?
, operates as a developer of novel small molecule antibiotics for the treatment of serious infections.
Where is Melinta Therapeutics headquartered?
Melinta Therapeutics is headquartered in Parsippany, US.
Which VCs invest in companies like Melinta Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Melinta Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Melinta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.